Clinical pharmacokinetics of cefixime : a systematic review
Cefixime is an antibiotic from the cephalosporin class used to treat various bacterial infections. The purpose of performing this review is to thoroughly evaluate the pharmacokinetic (PK) data on cefiximeFive databases were systematically searched to identify studies on the PK of cefixime.A total of 38 articles meeting the eligibility criteria were included that provide data on concentration-time profiles or PK parameters such as peak plasma and serum concentration (Cmax), area under the curve (AUC), clearance (CL), and time to reach Cmax (tmax). A dose-dependent increase in AUC and Cmax of cefixime was depicted in healthy volunteers. The clearance of cefixime decreased according to the degree of renal insufficiency among haemodialysis patients. A significant difference in CL was found in comparing fasted and fed states. A biphasic decline in serum concentrations of cefixime was reported when it was taken without probenecid.This review compiles all the reports on the PK of cefixime in healthy and really impaired patients; the summarised information can be used to optimise cefixime dosing in different disease states. Moreover, cefixime has increased time above MIC value suggesting that it may be an effective treatment for infections caused by certain pathogens.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Xenobiotica; the fate of foreign compounds in biological systems - 53(2023), 3 vom: 21. März, Seite 149-162 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ajmal, Maria [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
97I1C92E55 |
|---|
| Anmerkungen: |
Date Completed 07.06.2023 Date Revised 07.06.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/00498254.2023.2217265 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357189604 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357189604 | ||
| 003 | DE-627 | ||
| 005 | 20231226072042.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/00498254.2023.2217265 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1190.xml |
| 035 | |a (DE-627)NLM357189604 | ||
| 035 | |a (NLM)37216497 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ajmal, Maria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical pharmacokinetics of cefixime |b a systematic review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.06.2023 | ||
| 500 | |a Date Revised 07.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Cefixime is an antibiotic from the cephalosporin class used to treat various bacterial infections. The purpose of performing this review is to thoroughly evaluate the pharmacokinetic (PK) data on cefiximeFive databases were systematically searched to identify studies on the PK of cefixime.A total of 38 articles meeting the eligibility criteria were included that provide data on concentration-time profiles or PK parameters such as peak plasma and serum concentration (Cmax), area under the curve (AUC), clearance (CL), and time to reach Cmax (tmax). A dose-dependent increase in AUC and Cmax of cefixime was depicted in healthy volunteers. The clearance of cefixime decreased according to the degree of renal insufficiency among haemodialysis patients. A significant difference in CL was found in comparing fasted and fed states. A biphasic decline in serum concentrations of cefixime was reported when it was taken without probenecid.This review compiles all the reports on the PK of cefixime in healthy and really impaired patients; the summarised information can be used to optimise cefixime dosing in different disease states. Moreover, cefixime has increased time above MIC value suggesting that it may be an effective treatment for infections caused by certain pathogens | ||
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Cefixime | |
| 650 | 4 | |a clearance | |
| 650 | 4 | |a pharmacokinetic | |
| 650 | 4 | |a systematic review | |
| 650 | 4 | |a urinary tract infection | |
| 650 | 7 | |a Cefixime |2 NLM | |
| 650 | 7 | |a 97I1C92E55 |2 NLM | |
| 650 | 7 | |a Cefotaxime |2 NLM | |
| 650 | 7 | |a N2GI8B1GK7 |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Cephalosporins |2 NLM | |
| 700 | 1 | |a Zamir, Ammara |e verfasserin |4 aut | |
| 700 | 1 | |a Rehman, Anees Ur |e verfasserin |4 aut | |
| 700 | 1 | |a Imran, Imran |e verfasserin |4 aut | |
| 700 | 1 | |a Saeed, Hamid |e verfasserin |4 aut | |
| 700 | 1 | |a Majeed, Abdul |e verfasserin |4 aut | |
| 700 | 1 | |a Aziz, Majid |e verfasserin |4 aut | |
| 700 | 1 | |a Alqahtani, Faleh |e verfasserin |4 aut | |
| 700 | 1 | |a Rasool, Muhammad Fawad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Xenobiotica; the fate of foreign compounds in biological systems |d 1971 |g 53(2023), 3 vom: 21. März, Seite 149-162 |w (DE-627)NLM000064742 |x 1366-5928 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2023 |g number:3 |g day:21 |g month:03 |g pages:149-162 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/00498254.2023.2217265 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2023 |e 3 |b 21 |c 03 |h 149-162 | ||